Tampa General Hospital Implements AI-Powered Platform to Improve Operating Room Efficiency
Tampa General Hospital (TGH) has introduced Apella, an artificial intelligence (AI) platform designed to enhance safety and efficiency in its …
News
Blood Proteins Provide New Insights into Biological Aging and Disease Risk
A recent study from the University of Oxford reveals that proteins carried in the blood can offer significant insights into …
Insilico Medicine's AI-Designed TEAD Inhibitor Receives IND Approval and Orphan Drug Designation from FDA
Insilico Medicine, a clinical-stage biotechnology company specializing in generative AI-driven drug discovery, has announced that its novel compound, ISM6331, has …
Breaking: In Arguably the Largest AI in Bio Deal, Recursion Acquires UK-based "End-to-End" AI Biotech Exscientia
Recursion Pharmaceuticals, a biotech firm leveraging artificial intelligence (AI) for drug discovery, has announced its acquisition of Exscientia, a smaller …
Rollout of the First-Ever Blood Test for Alzheimer's Detection by Unilabs and C2N Diagnostics
Unilabs and C2N Diagnostics have announced a collaboration to launch the first-ever blood test for Alzheimer's disease detection in 75 …
Cell Microsystems Introduces Lab Services for Cell Line and Organoid Development
Cell Microsystems has expanded its contract research lab services to include cell line and custom organoid development, utilizing its proprietary …
3D-Printed Blood Vessels Edge Us Closer to Artificial Organs
Researchers at Harvard's Wyss Institute for Biologically Inspired Engineering and the John A. Paulson School of Engineering and Applied Science …
Riverlane Secures $75M for Quantum Error Correction Technology
Riverlane, a company based in Cambridge, UK, has raised $75 million in a Series C funding round to advance its …
UCLA Health Initiates Clinical Trial for Personalized Cancer Vaccine Targeting Aggressive Brain Tumors in Youth
Researchers at UCLA Health's Jonsson Comprehensive Cancer Center have launched a pioneering clinical trial to evaluate the safety and efficacy …
Lantern Pharma Reports 86% Clinical Benefit in NSCLC Trial, Initial Patient Cohort
Lantern Pharma has announced positive preliminary results from the ongoing Phase 2 HARMONIC clinical trial, targeting never smokers with advanced …
This Company Open Sources The Largest AI Foundation Model for Pathology
Paige, an AI-powered pathology solutions provider, has announced the open-source release of its AI models, Virchow and PRISM. Available on …
Healx Secures $47 Million in Series C Funding to Advance Rare Disease Treatments
Healx, a clinical-stage biotechnology company specializing in rare diseases, has successfully raised $47 million in a Series C funding round. …